• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过计算机模拟发现一种靶向PI3Kα治疗头颈部鳞状细胞癌的新型天然产物

In Silico Discovery of a Novel Natural Product Targeting PI3Kα for the Treatment of Head and Neck Squamous Cell Carcinoma.

作者信息

Jia Wenqing, Cheng Xianchao

机构信息

College of Chemistry and Chemical Engineering, Qilu Normal University, Jinan 250200, China.

Tianjin Key Laboratory on Technologies Enabling Development of Clinical Therapeutics and Diagnostics (Theranostics), School of Pharmacy, Tianjin Medical University, Tianjin 300070, China.

出版信息

Int J Mol Sci. 2025 Apr 10;26(8):3565. doi: 10.3390/ijms26083565.

DOI:10.3390/ijms26083565
PMID:40332095
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12027195/
Abstract

Head and neck squamous cell carcinoma (HNSCC) remains a major health burden, with abnormal activation of phosphatidylinositol 3-kinase alpha (PI3Kα) strongly implicated in its pathogenesis. Targeting PI3Kα represents a promising therapeutic strategy. In this study, we employed structure-based virtual screening to identify natural small-molecule inhibitors of PI3Kα. A total of 12,800 molecules were screened, and five compounds were selected for further evaluation based on binding affinity and interaction patterns. Pharmacokinetic properties were assessed using ADMET predictions, and molecular dynamics (MD) simulations were conducted to validate the binding stability. Among the candidates, Apigetrin demonstrated favorable ADMET properties, a high safety profile, and stable binding within the ATP-binding pocket of PI3Kα. These findings suggest that Apigetrin is a promising natural PI3Kα inhibitor with potential therapeutic relevance for HNSCC.

摘要

头颈部鳞状细胞癌(HNSCC)仍然是一项重大的健康负担,磷脂酰肌醇3-激酶α(PI3Kα)的异常激活与其发病机制密切相关。靶向PI3Kα是一种很有前景的治疗策略。在本研究中,我们采用基于结构的虚拟筛选来鉴定PI3Kα的天然小分子抑制剂。共筛选了12800个分子,并根据结合亲和力和相互作用模式选择了5种化合物进行进一步评估。使用ADMET预测评估药代动力学性质,并进行分子动力学(MD)模拟以验证结合稳定性。在候选物中,芹菜素表现出良好的ADMET性质、高安全性概况以及在PI3Kα的ATP结合口袋内的稳定结合。这些发现表明,芹菜素是一种有前景的天然PI3Kα抑制剂,对HNSCC具有潜在的治疗意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b3a/12027195/48bbcabb8ac7/ijms-26-03565-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b3a/12027195/23e6e2460a44/ijms-26-03565-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b3a/12027195/424094500d70/ijms-26-03565-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b3a/12027195/1471a39b11f9/ijms-26-03565-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b3a/12027195/3b0934ce9a34/ijms-26-03565-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b3a/12027195/bbb5789be099/ijms-26-03565-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b3a/12027195/43e4b333485f/ijms-26-03565-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b3a/12027195/dc7ae17dcb1f/ijms-26-03565-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b3a/12027195/48bbcabb8ac7/ijms-26-03565-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b3a/12027195/23e6e2460a44/ijms-26-03565-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b3a/12027195/424094500d70/ijms-26-03565-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b3a/12027195/1471a39b11f9/ijms-26-03565-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b3a/12027195/3b0934ce9a34/ijms-26-03565-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b3a/12027195/bbb5789be099/ijms-26-03565-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b3a/12027195/43e4b333485f/ijms-26-03565-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b3a/12027195/dc7ae17dcb1f/ijms-26-03565-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b3a/12027195/48bbcabb8ac7/ijms-26-03565-g008.jpg

相似文献

1
In Silico Discovery of a Novel Natural Product Targeting PI3Kα for the Treatment of Head and Neck Squamous Cell Carcinoma.通过计算机模拟发现一种靶向PI3Kα治疗头颈部鳞状细胞癌的新型天然产物
Int J Mol Sci. 2025 Apr 10;26(8):3565. doi: 10.3390/ijms26083565.
2
Identification of natural product as selective PI3Kα inhibitor against NSCLC: multi-ligand pharmacophore modeling, molecular docking, ADME, DFT, and MD simulations.天然产物作为针对非小细胞肺癌的选择性PI3Kα抑制剂的鉴定:多配体药效团建模、分子对接、药物代谢动力学/药物代谢和排泄、密度泛函理论及分子动力学模拟
Mol Divers. 2024 Oct;28(5):2983-3010. doi: 10.1007/s11030-023-10727-2. Epub 2023 Sep 15.
3
In silico discovery of a novel potential allosteric PI3Kα inhibitor incorporating 2-oxopropyl urea targeting head and neck squamous cell carcinoma.通过计算机模拟发现一种新型潜在变构PI3Kα抑制剂,其含有靶向头颈部鳞状细胞癌的2-氧代丙基脲。
BMC Chem. 2025 Feb 28;19(1):55. doi: 10.1186/s13065-025-01420-6.
4
Molecular Dynamics Simulations to Investigate the Binding Mode of the Natural Product Liphagal with Phosphoinositide 3-Kinase α.用于研究天然产物利普加格尔与磷脂酰肌醇3激酶α结合模式的分子动力学模拟
Molecules. 2016 Jun 29;21(7):857. doi: 10.3390/molecules21070857.
5
A deep learning-based theoretical protocol to identify potentially isoform-selective PI3Kα inhibitors.一种基于深度学习的理论方案,用于识别潜在的亚型选择性PI3Kα抑制剂。
Mol Divers. 2024 Aug;28(4):1907-1924. doi: 10.1007/s11030-023-10799-0. Epub 2024 Feb 2.
6
Identification of novel inhibitors targeting PI3Kα via ensemble-based virtual screening method, biological evaluation and molecular dynamics simulation.通过基于集成的虚拟筛选方法、生物学评价和分子动力学模拟鉴定新型 PI3Kα 抑制剂。
J Comput Aided Mol Des. 2024 Nov 11;38(1):37. doi: 10.1007/s10822-024-00580-2.
7
TAM family receptors in conjunction with MAPK signalling are involved in acquired resistance to PI3Kα inhibition in head and neck squamous cell carcinoma.TAM家族受体与丝裂原活化蛋白激酶(MAPK)信号传导共同参与头颈部鳞状细胞癌对PI3Kα抑制的获得性耐药。
J Exp Clin Cancer Res. 2020 Oct 15;39(1):217. doi: 10.1186/s13046-020-01713-9.
8
Identification of Novel PI3Kα Inhibitor Against Gastric Cancer: QSAR-, Molecular Docking-, and Molecular Dynamics Simulation-Based Analysis.基于 QSAR、分子对接和分子动力学模拟分析鉴定新型 PI3Kα 抑制剂抗胃癌
Appl Biochem Biotechnol. 2024 Oct;196(10):7233-7246. doi: 10.1007/s12010-024-04898-3. Epub 2024 Mar 20.
9
Novel pyrrolone-fused benzosuberene MK2 inhibitors: synthesis, pharmacophore modelling, molecular docking, and anti-cancer efficacy evaluation in HNSCC cells.新型吡咯酮并苯并[ b ]薁 MK2 抑制剂的合成、药效团建模、分子对接及在头颈癌细胞中的抗癌活性评价。
J Biomol Struct Dyn. 2024;42(21):11954-11975. doi: 10.1080/07391102.2023.2265993. Epub 2023 Oct 11.
10
Identification of novel potential PI3Kα inhibitors for cancer therapy.鉴定新型潜在的 PI3Kα 抑制剂用于癌症治疗。
J Biomol Struct Dyn. 2021 Jul;39(10):3721-3732. doi: 10.1080/07391102.2020.1771421. Epub 2020 Jun 1.

本文引用的文献

1
In silico discovery of a novel potential allosteric PI3Kα inhibitor incorporating 2-oxopropyl urea targeting head and neck squamous cell carcinoma.通过计算机模拟发现一种新型潜在变构PI3Kα抑制剂,其含有靶向头颈部鳞状细胞癌的2-氧代丙基脲。
BMC Chem. 2025 Feb 28;19(1):55. doi: 10.1186/s13065-025-01420-6.
2
Identification of acetylcholinesterase inhibitors and stability analysis of THC@HP-β-CD inclusion complex: A comprehensive computational study.乙酰胆碱酯酶抑制剂的鉴定及THC@HP-β-CD包合物的稳定性分析:一项全面的计算研究
Talanta. 2025 May 1;286:127370. doi: 10.1016/j.talanta.2024.127370. Epub 2024 Dec 9.
3
The multi-target mechanism of action of Selaginella doederleinii Hieron in the treatment of nasopharyngeal carcinoma: a network pharmacology and multi-omics analysis.
江南卷柏治疗鼻咽癌的多靶点作用机制:网络药理学与多组学分析
Sci Rep. 2025 Jan 2;15(1):159. doi: 10.1038/s41598-024-83921-3.
4
Atorvastatin inhibits glioma glycolysis and immune escape by modulating the miR-125a-5p/TXLNA axis.阿托伐他汀通过调节miR-125a-5p/TXLNA轴抑制胶质瘤糖酵解和免疫逃逸。
Hereditas. 2024 Dec 26;161(1):54. doi: 10.1186/s41065-024-00349-5.
5
Molecular Biology of Cancer-Interplay of Malignant Cells with Emerging Therapies.癌症分子生物学——恶性细胞与新兴疗法的相互作用
Int J Mol Sci. 2024 Dec 5;25(23):13090. doi: 10.3390/ijms252313090.
6
Design, synthesis, structural characterization, cytotoxicity and computational studies of Usnic acid derivative as potential anti-breast cancer agent against MCF7 and T47D cell lines.松萝酸衍生物作为针对MCF7和T47D细胞系的潜在抗乳腺癌药物的设计、合成、结构表征、细胞毒性及计算研究
Comput Biol Chem. 2025 Apr;115:108303. doi: 10.1016/j.compbiolchem.2024.108303. Epub 2024 Dec 2.
7
New advances in the therapeutic strategy of head and neck squamous cell carcinoma: A review of latest therapies and cutting-edge research.头颈部鳞状细胞癌治疗策略的新进展:最新疗法与前沿研究综述
Biochim Biophys Acta Rev Cancer. 2025 Feb;1880(1):189230. doi: 10.1016/j.bbcan.2024.189230. Epub 2024 Nov 26.
8
PINK1-deficiency facilitates mitochondrial iron accumulation and colon tumorigenesis.PINK1基因缺陷促进线粒体铁积累和结肠癌发生。
Autophagy. 2025 Apr;21(4):737-753. doi: 10.1080/15548627.2024.2425594. Epub 2024 Nov 16.
9
Inavolisib-Based Therapy in -Mutated Advanced Breast Cancer.伊沙匹隆为基础的疗法治疗 - 突变型晚期乳腺癌。
N Engl J Med. 2024 Oct 31;391(17):1584-1596. doi: 10.1056/NEJMoa2404625.
10
Free energy landscape of the PI3Kα C-terminal activation.磷脂酰肌醇-3激酶α(PI3Kα)C末端激活的自由能景观
Comput Struct Biotechnol J. 2024 Jul 8;23:3118-3131. doi: 10.1016/j.csbj.2024.07.010. eCollection 2024 Dec.